Meet
Kurt Nielsen
Kurt Nielsen
Bio
“One of my favorite quotes about leadership is, “Organizations don’t execute unless the right people, individually and collectively, focus on the right details at the right time.” This is what we strive to do at Longview Leader.”
My 25 years of experience in generic, brand, biotech, and consumer health pharmaceutical companies includes a strong background in managing businesses, developing and launching new products for global markets, regulatory strategy, sales and marketing of products and technologies, complex international licensing transactions, as well as, M&A. Additionally, my organizational leadership responsibilities in B2C and B2B companies includes a variety of entrepreneurial and corporate environments (e.g. matrixed global organizations with multiple business units), as well as, recruiting, building and retaining talented teams of leaders and managers.
I am currently, Senior Advisor and Co-Founder of Longview Leader. My previous leadership roles were President and CEO of Pharmaceutics International Inc. (Pii), a science-driven pharmaceutical contract development and manufacturing organization (CDMO) based in the US, President of Lupin Somerset (an Operating Division of Lupin, Inc) within Lupin Ltd. (BOM:500257) an innovation led transnational pharmaceutical company which is the 6th largest generics pharmaceutical company, VP of US Development, Portfolio and Launch Management at Sandoz Inc, part of the Novartis group (NYSE:NVS), Senior Vice President of R&D and Chief Technology Officer for Catalent Inc. (NYSE:CTLT), Executive Vice President of Pharmaceuticals for URL Pharma and Executive Director of Generic R&D for TEVA Pharmaceuticals (NYSE:TEVA).
There is no better teacher than experience. Put our experience to work enabling your organizational transformation, achievement of results, and accelerate growth.
What Our Clients Say
Some kind words from our respected clients